One click can help millions around the world. Every new healthcare professional who creates a free account on hcp.obgyn.net will trigger our donation of $10 to the international organization Doctors Without Borders/ Mdecins Sans Frontires (MSF) - a non-profit delivering emergency medical assistance in nearly 60 countries to people affected by armed conflict, epidemics, malnutrition, natural disasters, or exclusion from health care. It's our way of promoting global social good for doctors caring for those in desperate need. Our goal is to donate $25,000 - enough for vaccinations for 25,000 people against meningitis, measles, polio or other deadly epidemics.
One click can help millions around the world. Every new healthcare professional who creates a free account on hcp.obgyn.net will trigger our donation of $10 to the international organization Doctors Without Borders/ Mdecins Sans Frontires (MSF) - a non-profit delivering emergency medical assistance in nearly 60 countries to people affected by armed conflict, epidemics, malnutrition, natural disasters, or exclusion from health care. It's our way of promoting global social good for doctors caring for those in desperate need. Our goal is to donate $25,000 - enough for vaccinations for 25,000 people against meningitis, measles, polio or other deadly epidemics.
One click improves the care of patients in our local communities.
As a leader in providing highly respected and valued content and services to health care professionals in this country, we provide free content that helps medical practitioners like you become better, more effective and knowledgeable in the latest discoveries. In addition to our donation, your click will grant you access to free, timely content from hcp.obgyn.net to help keep you on the cutting edge of women's health.
One click starts the movement - together we can help save lives.
Thank you for spreading the word!
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More